Importantly, the expression of TIPE3 was positively correlated with pathological grading and HER2 expression, suggesting that elevated expression of TIPE3 may be correlated with the increase of malignancy degree in breast cancer tissue. Here, ERBB2 is linked to breast carcinoma.